PS Ratio: 10.34

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 10.34 is 100% below its estimated 1-year average of 10252.04, near the low end of its estimated 1-year range (10.34–108696.85).

As of 2026-10-06T13:35:34.684Z.

ASBP PS Ratio Metrics

P/S vs. estimated history

At 10.34, P/S is at an extreme level, where the multiple carries little signal — higher than 0% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Aspire Biopharma Holdings, Inc. (ASBP)?

The P/S ratio for ASBP stock is 10.34.

Is Aspire Biopharma Holdings, Inc.'s P/S ratio high or low?

The P/S ratio of 10.34 is 100% below its estimated 1-year average of 10252.04, near the low end of its estimated 1-year range (10.34–108696.85).

Related Metrics